Craft

XVIVO Perfusion

Stock Price

KR462

2024-10-29

Market Capitalization

KR14.6 B

2024-10-29

Revenue

KR812.2 M

FY, 2025

XVIVO Perfusion Summary

Company Summary

Overview
XVIVO Perfusion is a medical technology company that develops machines and perfusion solutions. Its products include Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solutions; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform for entire processing; and Liver Assist device for clinicians of perfusion protocols whether hypothermic and normothermic.
Type
Public
Status
Active
Founded
1998
HQ
Mölndal, SE | view all locations
Website
https://www.xvivoperfusion.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Gösta Johannesson

    Gösta Johannesson, Chairman of the Board & Remuneration Committee

    • Christoffer Rosenblad
    • Henrik Isaksson

      Henrik Isaksson, Director of Commercial Operations

    • Camilla Öberg

      Camilla Öberg, Chairman of the Audit Committee

    LocationsView all

    8 locations detected

    • Mölndal, Västra Götalands län HQ

      Sweden

      Gemenskapens gata 9

    • Aurora, CO

      United States

      3250 Quentin Street Suite 134

    • Englewood, CO

      United States

      3666 South Inca Street

    • Shanghai, Shang Hai Shi

      China

      22F, 1193 Changning Road

    • Novegro-Tregarezzo, Lombardia

      Italy

      Viale dell'Aviazione, 65

    • Groningen, GR

      Netherlands

      Bornholmstraat 84

    and 2 others

    XVIVO Perfusion Financials

    Summary Financials

    Revenue (Q1, 2026)
    kr241.0M
    Gross profit (Q1, 2026)
    kr190.8M
    Net income (Q1, 2026)
    kr36.3M
    Cash (Q1, 2026)
    kr308.1M
    EBIT (Q1, 2026)
    kr31.9M
    Enterprise value
    $14.4B

    Footer menu